Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Oct 3 2025
Sep 28 2025
Jan 6 2026
Jun 13 2026
May 9 2026